ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Total Non-current Liabilities

All obligations due after more than one year.

No reported Total Non-current Liabilities figures are available to summarize.

Total Non-current Liabilities history

Currency unavailable · from the balance sheet

No Total Non-current Liabilities data reported for this period type.

Total Non-current Liabilities vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Total Non-current Liabilities for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRMEPrime Medicine, Inc.Mar 2026$181.74M USD-2.8%+120.0%61.7%
MGTXMeiraGTx Holdings plcMar 2026$126.66M USD-8.6%+2.5%51.8%
SLNSilence Therapeutics plcMar 2026$55.26M USD-80.2%-4.4%48.0%
RNAAtrium Therapeutics, Inc.Mar 2026$36.35M USD——12.4%
PRQRProQR Therapeutics N.V.Mar 2026€26.41M EUR-37.4%-28.2%26.6%
WVEWave Life Sciences Ltd.Mar 2026$21.98M USD-24.6%-47.7%3.8%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$19.68M USD-59.5%-26.8%8.0%
STOKStoke Therapeutics, Inc.Mar 2026$7.59M USD-37.4%-41.2%1.7%
BNTCBenitec Biopharma Inc.Mar 2026$394K USD-35.7%-4.0%0.2%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-36.6%-15.6%12.4%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.